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Abstract
Background
Although endoscopic submucosal dissection (ESD) is routinely performed under sedation,
the difference in ESD performance according to sedation method is not well known. This
study attempted to prospectively assess and compare the satisfaction of the endoscopists
and patient stability during ESD between two sedation methods.
Methods
One hundred and fifty-four adult patients scheduled for ESD were sedated by either the
IMIE (intermittent midazolam/propofol injection by endoscopist) or CPIA (continuous propo-
fol infusion by anesthesiologist) method. The primary endpoint of this study was to compare
the level of satisfaction of the endoscopists between the two groups. The secondary end-
points included level of satisfaction of the patients, patient’s pain scores, events interfering
with the procedure, incidence of unintended deep sedation, hemodynamic and respiratory
events, and ESD outcomes and complications.
Results
Level of satisfaction of the endoscopists was significantly higher in the CPIA Group com-
pared to the IMIE group (IMIE vs. CPIA; high satisfaction score; 63.2% vs. 87.2%,
P=0.001). The incidence of unintended deep sedation was significantly higher in the IMIE
Group compared to the CPIA Group (IMIE vs. CPIA; 17.1% vs. 5.1%, P=0.018) as well as
the number of patients showing spontaneous movement or those requiring physical re-
straint (IMIE vs. CPIA; spontaneous movement; 60.5% vs. 42.3%, P=0.024, physical re-
straint; 27.6% vs. 10.3%, P=0.006, respectively). In contrast, level of satisfaction of the
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patients were found to be significantly higher in the IMIE Group (IMIE vs. CPIA; high satis-
faction score; 85.5% vs. 67.9%, P=0.027). Pain scores of the patients, hemodynamic and
respiratory events, and ESD outcomes and complications were not different between the
two groups.
Conclusion
Continuous propofol and remifentanil infusion by an anesthesiologist during ESD can in-
crease the satisfaction levels of the endoscopists by providing a more stable state
of sedation.
Trial Registration
ClinicalTrials.gov NCT01806753
Introduction
Since it was first developed in the late 1990s, endoscopic submucosal dissection (ESD) has
gained much popularity and has been proven to be superior to endoscopic mucosal resection
(EMR) by showing higher rates of en-bloc resection in larger tumors and in expanded indica-
tions for endoscopic resection of early gastric cancer [1]. However, despite the continuous de-
velopment in endoscopic devices, ESD is still a technically challenging procedure and usually
takes longer than EMR [1–3]. The risk of complications such as perforation [4] and bleeding
[5] is known to increase with such lengthy procedures, as well as patient discomfort and pain.
Minimizing patient movement can therefore be said to be of key importance for a successful
procedure, and it has been suggested by many that deep sedation is preferable during ESD in
order to enhance the safety and precision of the procedure [3,6]. However, methods of propo-
fol-based moderate sedation have been recently found to be a safe and effective option during
therapeutic gastrointestinal (GI) endoscopic procedures by providing better patient coopera-
tion [7,8].
In terms of sedative agents, propofol has greatly replaced the role of benzodiazepines during
the past decade, and better results with propofol sedation during ESD have been reported in
several studies [9–11]. The main problems with propofol, however, were its narrow therapeutic
window, lack of reversal agent and considerable risk of respiratory depression [12]. This has re-
sulted in many studies aimed to resolve the issue of ‘who’ should administrate propofol and
‘how’ it should be done with regard to safety, cost and legal aspects [13–16]. On the other
hand, the relationship between sedation methods and performance of ESD has not been widely
studied. A recent retrospective analysis found the sedation method to significantly affect clini-
cal outcomes of ESD [17]. More specifically, this study concluded that continuous propofol in-
fusion supplemented with opioid administration by anesthesiologists improved ESD
performance by increasing en bloc resection and complete resection rates and reducing proce-
dure time, compared to intermittent bolus injection of midazolam and propofol by endosco-
pists. These results were largely attributed to the enhanced stability of the procedure by a
decrease in patient movement and other events that may interrupt a smooth intervention, and
a general increase in the satisfaction of the endoscopists was also assumed with continuous
propofol infusion used by the anesthesiologists. However, this study failed to present satisfac-
tion scores of the endoscopists or the patients, and had the limitation of being a retrospective
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analysis. We therefore aimed to prospectively assess the satisfaction of the endoscopists as well
as patient stability during ESD procedures according to sedation method in the present study.
Patients and Methods
The protocol for this trial and supporting CONSORT checklist are available as supporting in-
formation; see S1 Checklist and S1 Protocol.
Study population
The study protocol was approved by the Institutional Review Board and Hospital Research
Ethics Committee of Severance Hospital, and registered at http://clinicaltrials.gov (registration
number NCT01806753). Adult patients between the age of 20 to 80 years that were diagnosed
with early gastric cancer or adenoma and scheduled for ESD were recruited for this study. All
patients were of ECOG performance status 0 or 1 and American Society of Anesthesiologists
(ASA) physical status I~III. Written informed consent was obtained from all patients. Patients
that had previously undergone subtotal gastrectomy or gastrostomy, those receiving repeated
ESD or presenting with three or more synchronous lesions were excluded from this study.
Pregnant or breastfeeding patients and those with known allergies to eggs, soy beans or sulfites
were excluded from this study. Patients that had received sedation for another procedure with-
in 24 hours prior to ESD, those with debilitating neurologic or psychotic disorders or unable to
provide informed consent were also excluded.
Study design, sedation protocols and method of ESD
Enrolled patients were randomly assigned in a 1:1 ratio by using a table of computer-generated
random numbers with sealed envelopes to either the IMIE (intermittent midazolam/propofol
injection by endoscopist) Group or the CPIA (continuous propofol infusion by anesthesiolo-
gist) Group. This was created by one of the investigators (CHP) by applying a block randomi-
zation method with a block size of four. Although the patients remained blinded to group
assignment until discharge, endoscopists inevitably became aware of the sedation method used
in each patient while performing ESD.
The targeted level of sedation was Modified Observer’s Assessment of Alertness/Sedation
(MOAA/S) score of 3 or 4 in both groups (Table 1) [18]. Sedation in the IMIE Group was done
by endoscopists who were not involved in the endoscopic procedure. All three endoscopists per-
forming sedation were familiar with procedural sedation, and were fully informed of the sedation
protocols of the present study. Sedation was started by administrating an initial bolus of 50 mg of
meperidine intramuscularly, and 0.05 mg/kg of intravenous (IV) midazolam. When patients
were found to be undersedated with an MOAA/S score of 5 or 6, bolus doses of 0.25 mg/kg of
Table 1. Modified Observer’s Assessment of Alertness/Sedation Scale [18].
Responsiveness Score
Agitated 6
Responds readily to name spoken in normal tone (alert) 5
Lethargic response to name spoken in normal tone 4
Responds only after name is called loudly and/or repeatedly 3
Responds only after mild prodding or shaking 2
Does not respond to mild prodding or shaking 1
Does not respond to deep stimulus 0
doi:10.1371/journal.pone.0120529.t001
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propofol were given to maintain the targeted depth of sedation. Patients showing signs of dis-
comfort or pain such as spontaneous movements while presenting with an MOAA/S score of 3
or 4 were assessed as inappropriate analgesia, and were given additional bolus doses of meperi-
dine 12.5 mg intravenously. Sedation in the CPIA Group was performed by a three qualified
anesthesiology staff members trained for procedural sedation outside the operating theater. Ini-
tial bolus doses of 0.5 μg/kg of remifentanil and 0.5 mg/kg of propofol were followed by continu-
ous infusions of remifentanil and propofol at 0.08 μg/kg/min and 2 mg/kg/hr, respectively by
using an automated pump. Undersedated patients presenting with an MOAA/S score of 5 or 6
were given additional bolus doses of 0.25 mg/kg propofol and the infusion rate was increased by
0.5 mg/kg/hr. Patients of MOAA/S score 3 or 4 and showing signs of discomfort or pain were
given additional analgesia by increasing the infusion rate of remifentanil by 0.02 μg/kg/min.
When the mean blood pressure of the patient fell below 60 mmHg or decreased by more than
20% from baseline, or the patient showed desaturation of SpO2<90%, propofol infusion rates
were decreased by 0.5 mg/kg/hr.
Four attending gastroenterologists performed the ESD procedures in this study. All ESD pro-
cedures were performed with a standard single-channel endoscope. The typical procedure se-
quence consisted of marking, mucosal incision, and submucosal dissection with simultaneous
hemostasis. After making several marking dots circumferentially around the lesion with a needle
knife or a needle knife papillotome, a saline solution containing epinephrine (0.01 mg/mL)
mixed with 0.8% indigo carmine was injected into the submucosal layer using a 21-gauge needle
to lift the lesion away from the muscle layer. A circumferential incision was made in the mucosa
using a needle knife and an insulated-tip knife. The submucosal layer was dissected directly with
various knives until complete removal was achieved. Endoscopic hemostasis was performed
with hemoclips or hemostatic forceps whenever bleeding or exposed vessels were observed.
Patient monitoring
All ESD procedures were performed in a room dedicated to upper gastrointestinal endoscopy
and fully equipped for advanced cardiac life support. Patients were to arrive at the endoscopy
room with secure IV access, and were administered normal saline or Hartmann solution as ap-
propriate. Nasal oxygen was supplied at 2 L/min. Patient monitoring included noninvasive
blood pressure measurements every 5 minutes, pulse oximetry (SpO2), electrocardiography
and respiratory activity via thoracic leads. Depth of sedation was assessed by the MOAA/S
score at four time points; just before the insertion of the endoscope, after insertion of the endo-
scope and before the first incision, immediately after the first incision and at the end of dissec-
tion. Additional assessments of sedation depth were done when patients showed signs of
undersedation or reactions to discomfort and/or pain. At the end of ESD, patients were trans-
ferred to the endoscopy recovery unit and monitored by noninvasive blood pressure, pulse ox-
imetry and electrocardiography. Assessment of recovery was done by dedicated nursing staff
by using the modified Aldrete score every 5 minutes until discharge [19].
Outcome measures
Before the procedure, demographic data of the patients including age, sex, height, weight,
smoking history, underlying diseases, and medication history were obtained. In addition,
tumor location and macroscopic types were endoscopically evaluated and classified according
to the Japanese Gastric Cancer Association Classification [20]. Tumor size, presence of ulcera-
tion, invasion depth, lymphatic and vascular involvement, and tumor involvement at the lateral
and vertical margins were histopathologically assessed. During the procedure, the following se-
dation-related events were observed and collected: episodes of unintended deep sedation,
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events intefering with the procedure (belching, vomiting, spontaneous movements and the
need for physical restraint), hemodynamic events (hypertension, hypotension, tachycardia,
and bradycardia), and respiratory events (chin lift/jaw thrust maneuver, increase in oxygen
flow, and assisted mask ventilation). The endoscopists gave their satisfaction scores at the end
of the procedure on a verbally administered numerical rating scale of 0 to 10, which were later
categorized as satisfaction levels of either low (0–3), medium (4–6), or high (7–10), for analysis.
Satisfaction scores of the patients were assessed and categorized in the same manner as the
endoscopists at the following morning after the procedure. Pain scores of the patients were as-
sessed after full recovery at the endoscopy recovery unit and at the following morning after the
procedure on a visual analogue scale of 0 to 10, 0 meaning no pain and 10 meaning worst pain
imaginable. Finally, ESD outcomes including en-bloc resection, complete resection, and cura-
tive resection and ESD complications including post-procedural bleeding, peforation, and aspi-
ration pneumonia were assessed.
Definitions
Procedure time was defined as time frommarking to complete removal, including the time re-
quired for hemostasis. MOAA/S scores lower than 3 were defined as unintended deep sedation,
and events interfering with the procedure were noted as belching, vomiting, spontaneous move-
ment or uncooperative patients requiring physical restraint. Respiratory events were defined as
apnea or desaturation (SpO2< 90%) that required either a chin lift or jaw thrust maneuver, an
increase in O2 flow or assisted mask ventilation. Hypertension was defined as a greater than
20% increase in mean blood pressure from baseline. Hypotension was defined as when the
mean blood pressure of the patient fell below 60 mmHg or decreased by more than 20% from
baseline. Tachycardia and bradycardia were each defined as a heart rate>120 beats/min and
<50 beats/min, respectively. Full recovery of the patients was defined as an Aldrete score of 10.
En bloc resection was defined as the resection of a single piece, as opposed to the resection
of multiple pieces. Complete resection was defined as tumor-free lateral and vertical margins
on histologic examination. Curative resection was defined as an en bloc resected lesion with
negative margins of neoplasm and which fulfilled the criteria of node-negative neoplasms with
no lymphovascular infiltration.
Study endpoints
The primary endpoint of this study was to compare the level of satisfaction of the endoscopists
between the two groups. In addition, the following secondary endpoints were assessed: level of
satisfaction of the patients, patient’s pain scores, events interfering with the procedure, inci-
dence of unintended deep sedation, hemodynamic and respiratory events, outcomes of ESD in-
cluding en-bloc, complete, and curative resection, and complications of ESD including post-
procedural bleeding, perforation, and aspiration pneumonia.
Statistical analysis
Sample size calculation was performed using a χ2 test based on the results of our pilot study.
Number of patients according to the satisfaction level was as follows: one with low satisfaction
scores (0–3), one with medium satisfaction scores (4–6), and eight with high satisfaction scores
(7–10) under the CPIA method, and one with low satisfaction scores (0–3), three with medium
satisfaction scores (4–6), and six with high satisfaction scores (7–10) under the IMIE method.
Based on the results of the pilot study, the effect size was estimated as 0.25. In addition, the de-
gree of freedom was two because values of the primary outcome were classified into a 2 x 3 con-
tingency table. As a result, a sample size of 155 would be needed to achieve 80% power to
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detect an effect size of 0.25 using a χ2 test with 2 degrees of freedom, with a significance level of
0.05. We recruited 157 patients considering a 1% dropout rate. Continuous variables with nor-
mal distribution were analyzed with the independent two sample t-test. Categorical variables
were analyzed by the χ2 or Fisher’s exact test. In order to adjust possible confounding variables,
the primary outcome was further analyzed by logistic regression analysis. All statistical analyses
were performed with IBM SPSS Statistics 20.0 (IBM Corp., Armonk, NY, USA). A P value of
<0.05 was considered statistically significant.
Results
The CONSORT flow diagram of this study is shown in Fig. 1. Among the 157 patients that
were assessed for eligibility between March and December 2013, 2 patients that underwent
endoscopic ultrasound under sedation just before ESD and 1 patient that declined to partici-
pate were excluded from the study. The remaining 154 patients were randomly assigned to ei-
ther the IMIE Group (n = 76) or the CPIA Group (n = 78). After randomization, all patients
received their allocated intervention and none were lost to follow-up or excluded
from analysis.
Fig 1. CONSORT flow chart of patient sample selection.
doi:10.1371/journal.pone.0120529.g001
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Demographic data
Demographic data are shown in Table 2. There were no differences in patient age, sex, body
mass index, smoking history, ASA physical status distribution or the history of the use of anti-
platelet agents or anticoagulants between the two groups. Antiplatelet agents and anticoagu-
lants were discontinued in all patients prior to endoscopic submucosal dissection.
Lesion characteristics and outcomes of endoscopic submucosal
dissection
The numbers of lesions were 78 and 82 in the IMIE and CPIA Group, respectively. There was
no difference between the two groups with regard to the location of lesions, macroscopic ap-
pearance, histology or size of the lesions. Ulceration was not found in any of the lesions of both
groups. Depth of invasion or the incidence of lymphovascular invasion was also comparable
between groups, as well as the outcomes and complications of ESD (Table 3).
Sedation-related data, speed of recovery and satisfaction scores
Table 4 shows data relevant to sedation, recovery, and satisfaction scores of the endoscopists
and patients in all of the procedures. Procedure time was not significantly different between
the two groups. The proportion of patients that reached complete recovery within 5 minutes of
admission to the endoscopy recovery unit was significantly greater in the CPIA Group com-
pared to the IMIE Group (P = 0.001). All patients in both groups were able to recover fully
within 10 minutes.
Level of satisfaction of the endoscopists was found to be significantly different between the
two groups, with the CPIA Group showing a higher degree of satisfaction (P = 0.001). In
Table 2. Demographic data.
Variable IMIE CPIA P value
(n = 76) (n = 78)
Age (years) 63.3 ± 8.8 61.0 ± 9.5 0.125
Sex, n (%) 0.442
Male 55 (72.4) 52 (66.7)
Female 21 (27.6) 26 (33.3)
Body mass index (kg/m2) 23.6 ± 3.2 24.2 ± 2.2 0.187
Smoking history, n (%) 0.381
Smoker 23 (30.3) 17 (21.8)
Ex-smoker 20 (26.3) 27 (34.6)
Non-smoker 33 (43.4) 34 (43.6)
ASA physical status, n (%) 0.127
1 51 (67.1) 43 (55.1)
2 21 (27.6) 24 (30.8)
3 4 (5.3) 11 (14.1)
Use of antiplatelet agents or anticoagulants,a n (%) 4 (5.3) 10 (12.8) 0.103
Values are mean ± SD or n (%) of patients.
aAntiplatelet agents or anticoagulants include aspirin, non-steroidal anti-inﬂammatory drugs and warfarin. The aforementioned drugs were discontinued in
all patients prior to endoscopic submucosal dissection. ‘Use of antiplatelet agents or anticoagulants’ indicates the number of patients who took
these medications.
IMIE, intermittent midazolam/propofol injection by endoscopist; CPIA, continuous propofol infusion by anesthesiologist; ASA, American Society of
Anesthesiologists.
doi:10.1371/journal.pone.0120529.t002
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contrast, level of satisfaction of the patients were found to be significantly higher in the IMIE
Group compared to the CPIA Group (P = 0.027). Pain scores reported by the patients were not
different between the two groups both immediately after and at the following morning after
the procedure. The logistic regression model shown in Table 5 confirmed that the CPIA group
was associated with higher satisfaction scores under adjusting for possible confounding vari-
ables (odds ratio [95% confidence interval] = 4.217 [1.840–9.668]).
Adverse events
Adverse events were shown in Table 6. The incidence of unintended deep sedation was found
to be significantly higher in the IMIE Group compared to the CPIA Group (P = 0.018). Among
the events interfering with the procedure, the incidence of belching or vomiting was not
Table 3. Lesion characteristics and outcomes of endoscopic submucosal dissection.
Variable IMIE CPIA P value
Number of lesions 78 82
Location of lesions, n (%) 0.981
Upper third 6 (7.7) 7 (8.5)
Middle third 28 (35.9) 29 (35.4)
Lower third 44 (56.4) 46 (56.1)
Macroscopic appearance, n (%) 0.675
Elevated 51 (65.4) 51 (62.2)
Flat or depressed 27 (34.6) 31 (37.8)
Presence of ulcer, n (%) 0 (0.0) 0 (0.0) N/A
Histology, n (%) 0.661
Adenoma 46 (59.0) 44 (53.7)
Differentiated cancer 29 (37.2) 36 (43.9)
Undifferentiated cancer 3 (3.8) 2 (2.4)
Lesion size, n (%) 0.224
 10 mm 43 (55.1) 34 (41.5)
10 to 20 mm 24 (30.8) 33 (40.2)
> 20 mm 11 (14.1) 15 (18.3)
Depth of invasion,a n (%) 0.617
Mucosa 25 (78.1) 31 (81.6)
Submucosa (< 500 μm) 5 (15.6) 3 (7.9)
Submucosa ( 500 μm) 2 (6.3) 4 (10.5)
Lymphovascular invasion, a n (%) 3 (9.4) 4 (10.5) > 0.999
Outcomes of ESD, n (%)
En-bloc resection 76 (97.4) 82 (100.0) 0.236
Complete resection 75 (96.2) 81 (98.8) 0.358
Curative resection 69 (88.5) 76 (92.7) 0.360
Complications of ESD, n (%)
Post-procedural bleeding 2 (2.6) 3 (3.7) > 0.999
Perforation 0 (0.0) 1 (1.2) > 0.999
Pneumoniab 0 (0.0) 0 (0.0) N/A
aThe percentage of this variable was calculated based on the number of early gastric cancer lesions.
bThe percentage of this variable was calculated based on the number of patients.
IMIE, intermittent midazolam/propofol injection by endoscopist; CPIA, continuous propofol infusion by
anesthesiologist; ESD, endoscopic submucosal dissection; N/A, not applicable.
doi:10.1371/journal.pone.0120529.t003
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Table 4. Sedation-related data, speed of recovery and satisfaction scores.
Variable IMIE CPIA P value
(n = 76) (n = 78)
Procedure time, min 33.3 ± 21.8 38.0 ± 24.1 0.207
Drug requirements for sedation
Midazolam, mg/kg 0.06 ± 0.01
Pethidine, μg/kg/min 35.2 ± 17.4
Propofol, μg/kg/min 46.6 ± 26.2 63.2 ± 33.1
Remifentanil, μg/kg/hr 6.7 ± 3.7
Speed of recovery, n (%)
Within 5 minutes 57 (75.0) 74 (94.9) 0.001
Within 10 minutes 76 (100.0) 78 (100.0) N/A
Level of satisfaction of the endoscopists, n (%) 0.001
Low 6 (7.9) 1 (1.3)
Medium 22 (28.9) 9 (11.5)
High 48 (63.2) 68 (87.2)
Level of satisfaction of the patients, n (%) 0.027
Low 2 (2.6) 8 (10.3)
Medium 9 (11.8) 17 (21.8)
High 65 (85.5) 53 (67.9)
Patient's pain score
Immediately after the procedure 0.8 ± 1.5 1.1 ± 1.6 0.281
At the following morning after the procedure 2.8 ± 2.2 3.0 ± 1.7 0.374
Values are mean ± SD or n (%) of patients.
IMIE, intermittent midazolam/propofol injection by endoscopist; CPIA, continuous propofol infusion by anesthesiologist; N/A, not applicable.
doi:10.1371/journal.pone.0120529.t004
Table 5. Associate factor for affecting high satisfaction score of endoscopist.
Variable n High satisfaction score OR (95% CI) P value
n (%)
Number of lesions
One 148 112 (75.7) 1
Two 6 4 (66.7) 0.541 (0.083–3.512) 0.519
Histology
Adenoma 84 62 (73.8) 1
Cancer 70 54 (77.1) 1.151 (0.513–2.584) 0.733
Location
Upper or middle third 70 53 (75.7) 1.089 (0.484–2.447) 0.837
Lower third 84 63 (75.0) 1
Procedure time, min N/A N/A 0.992 (0.975–1.009) 0.365
Sedation method
IMIE 76 48 (63.2) 1
CPIA 78 68 (87.2) 4.217 (1.840–9.668) 0.001
IMIE, intermittent midazolam/propofol injection by endoscopist; CPIA, continuous propofol infusion by anesthesiologist; OR, odds ratio; CI, conﬁdence
interval; N/A, not applicable.
doi:10.1371/journal.pone.0120529.t005
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different between the two groups. However, patients showing spontaneous movement or those
requiring physical restraint due to uncooperative behavior were observed more often in the
IMIE Group compared to the CPIA Group (P = 0.024 and 0.006, respectively). In addition,
there was no difference between groups with regard to the incidence of other respiratory events
or hemodynamic events. There was no serious adverse event in both groups.
Discussion
Providing sedation during GI endoscopic procedures has now become standard of care [18,21],
and despite much controversy, propofol has gained popularity as the sedative of choice by
many endoscopists as well as anesthesiologists [9–11,22,23]. As of now, whether or not to use
propofol during sedation for GI endoscopy no longer seems to be an issue. Rather, who and
how that person should administer propofol in order to maximize the clinical outcomes rele-
vant to sedation method are hotly debated. Compared to the abundance of studies focused on
safety outcomes, little is known on the difference in ESD performance according to method of
sedation. To the best of our knowledge, the present study is the first to investigate how sedation
method during ESD affects the satisfaction levels of the endoscopists.
Table 6. Adverse events.
Variable IMIE CPIA P value
(n = 76) (n = 78)
Patients with at least one episode of unintended deep sedation (MOAA/S
0 ~ 2), n (%)
13
(17.1)
4 (5.1) 0.018
Events interfering with procedure, n (%)
Belching 18
(23.7)
16
(20.5)
0.635
Vomiting 1 (1.3) 1 (1.3) > 0.999
Spontaneous movement 46
(60.5)
33
(42.3)
0.024
Requiring physical restraint 21
(27.6)
8 (10.3) 0.006
Any of the above 51
(67.1)
41
(52.6)
0.066
Respiratory events, n (%)
Chin lift/jaw thrust maneuver 11
(14.5)
10
(12.8)
0.765
Increase in O2 ﬂow 2 (2.6) 6 (7.7) 0.276
Assisted mask ventilation 1 (1.3) 2 (2.6) > 0.999
Any of the above 11
(14.5)
11
(14.1)
0.948
Hemodynamic events, n (%)
Hypertension 15
(19.7)
22
(28.2)
0.219
Hypotension 3 (3.9) 2 (2.6) 0.679
Tachycardia 2 (2.6) 7 (9.0) 0.167
Bradycardia 0 (0.0) 1 (1.3) > 0.999
Any of the above 19
(25.0)
29
(37.2)
0.103
IMIE, intermittent midazolam/propofol injection by endoscopist; CPIA, continuous propofol infusion by
anesthesiologist; MOAA/S, modiﬁed observer assessment of alertness/sedation.
doi:10.1371/journal.pone.0120529.t006
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It is important to acknowledge the components of the two different sedation methods used
in this study. The IMIE Group basically employs the method of intermittent bolus administra-
tions of propofol supplemented by bolus doses of meperidine for pain control, which are given
by an endoscopist. While propofol is also used as the main sedative, the CPIA Group differs
from the IMIE Group in that both propofol and remifentanil is administered by continuous in-
fusion, a method often advocated by anesthesiologists for monitored anesthesia care [24].
Although continuous propofol infusion with opioid administration by an anesthesiologist
had been previously suggested as a risk factor for post-ESD pneumonia by Park et al. [25], the
depth of sedation was not controlled in their study. Another study reported significantly slower
recovery times and a higher incidence of hypotension with continuous propofol infusion by a
trained nurse, when deep sedation was targeted during GI endoscopy [26]. In contrast, overall
quality of sedation, operating conditions and clinical recovery profiles were found to be compa-
rable between intermittent bolus injection, variable-rate continuous infusion and target-con-
trolled infusion of propofol when a moderate depth of sedation was targeted during monitored
anesthesia care for breast biopsy [27]. Taken together with the results of the present study, a
strictly controlled moderate level of sedation may be of vital importance in achieving better
procedural outcome. The proportion of patients that showed at least one episode of unintended
deep sedation was significantly greater in the IMIE Group compared to the CPIA Group in this
study. While this may be partially attributable to the familiarity with titrating drug infusion
rates and the ability to maintain a more stable level of sedation of the anesthesiologist, the dif-
ference in opioids used in each group should also be taken into account. Patel et al. [28] re-
ported that the incidence of unintended deep sedation during sedation with midazolam and
meperidine was as high as 85% during endoscopic retrograde cholangiopancreatography
(ERCP). They also found a more frequent occurrence of deep sedation with advanced endo-
scopic procedures such as ERCP and endoscopic ultrasound, compared to simple diagnostic
procedures such as esophagogastroduodenoscopy and colonoscopy. This was assumed to be
probably related to greater total sedative-analgesic doses during prolonged complex procedures
and the pharmacokinetics of midazolam and meperidine. Midazolam and meperidine both
have slower onset times and longer half-lives compared to propofol and remifentanil [6,29],
which will render the former combination of drugs more prone to a slower-than-desired speed
of titration and the tendency for oversedation.
The speed of recovery was found to be significantly faster in the CPIA Group, with more pa-
tients showing full recovery within 5 minutes after ESD. This also seems to be attributable to
the aforementioned difference in agents, rather than method of drug delivery. Hayee et al. [30]
found that recovery time was significantly shorter in patients receiving fentanyl than those re-
ceiving meperidine for sedation with midazolam during colonoscopy. Considering that the
half-life of remifentanil is even shorter that fentanyl [29], the faster recovery in the CPIA
Group compared to the IMIE Group seems natural.
The most interesting aspect of this study seems to be the contradicting results of the satisfac-
tion levels of the endoscopists and the patients. The satisfaction of the endoscopists during pro-
cedures that are performed under moderate sedation can be expected to be determined largely
by the cooperativeness of the patient and the overall stability of sedation. An uncooperative pa-
tient showing sudden movements will hinder the safety and precision of the procedure, and
may require physical restraint in order to secure the patient. A cooperative patient can be easily
judged to be one under bearable circumstances, if not completely comfortable. In terms of
events interfering with the procedure, the incidence of spontaneous movements of the patients,
and more importantly, patients requiring physical restraint were significantly lower in the
CPIA Group. However, the satisfaction levels of the endoscopists and the patients are opposing
in the present study, which seem to contradict the common perception of a ‘cooperative
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patient’. In addition to decreasing anxiety and discomfort of the patient, amnesia is considered
as one of the goals of sedation for endoscopy [31], and this may have affected the satisfaction
levels of the patients. Although the patient may seem perfectly comfortable and cooperative
during the procedure, the fact that he or she is able to recall the events afterwards may have
been a source of dissatisfaction with the whole procedure. A key characteristic of benzodiaze-
pines is their amnestic property [6], and the bolus dose of midazolam that was given in the
IMIE Group at the beginning of sedation may have contributed to these results. Adding a small
dose of midazolam to the CPIA regimen may possibly help in overcoming this problem.
This study is not without limitations. First of all, the causes of low satisfaction scores in
some patients were not evaluated. Although the primary outcome of the present study was the
satisfaction levels of the endoscopists, the conflicting results seen in patient satisfaction cannot
be ignored. The cause of dissatisfaction of the patients may have been due to several reasons
such as lack of analgesia or amnesia, and investigating this aspect would have provided more
insight into how the sedation protocols could be improved in the future. Secondly, the sedation
providers were different between the two groups. Although one may speculate that a trained
anesthesiologist would probably be more skillful in procedural sedation, the difference in seda-
tive regimen and administration technique cannot be ruled out as contributing factors. A ran-
domized trial comparing only the regimen itself or sedation provider is needed to discern the
major factor affecting the results. Another important limitation is that most of the endoscopists
were aware of the sedation method during ESD. This study had been initially planned to be car-
ried out with both the patients and endoscopists blinded to the sedation method, but this
proved to be practically impossible in the clinical setting. Concealing the identity of the clini-
cian providing sedation from the endoscopist was extremely difficult, and thus only the patient
remained completely blinded to group allocation. Although this may have been a source of bias
in the reporting of satisfaction scores, the endoscopists were informed to be as objective as pos-
sible in reporting their opinions. Finally, although this study showed the comparisons of seda-
tion-related outcomes between the two sedation methods during gastric ESD, it is unclear
whether the results of the study are applicable to other ESD procedures. For example, colonic
ESD requires greater endoscopic skill compared to gastric ESD because of anatomical features
of the colon including its longer length, narrow lumen, extensive flexion and thinner walls
[32]. More studies on ESD for gastrointestinal lesions other than gastric neoplasms are needed
to generalize about our results.
In conclusion, this study shows that continuous propofol and remifentanil infusion by an
anesthesiologist during ESD can increase the satisfaction levels of the endoscopists by provid-
ing a more stable state of sedation. These results, however, should be cautiously interpreted be-
cause the endoscopists were aware of sedation methods during ESD. Together with this
finding, a further investigation on improving patient satisfaction may be able to offer support-
ing evidence for a more ideal sedation regimen for smooth ESD procedures.
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